The life sciences industry is one of the most complex, contentious and rapidly
developing fields. In order to prepare for Brexit and the forecasted uncertainty,
companies need to ensure their portfolio is sustainable, flexible and robust to manage
IP and regulatory enforcement over the coming months.
Jason Rutt is speaking at this event.